Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kursk Biofactory, operating under the brand name Biolok, is a major Russian biotechnology enterprise specializing in the production of veterinary biologicals and pharmaceutical products. Founded in 1896, it is one of the oldest and most significant facilities in Russia for the manufacture of vaccines and diagnostic systems for animal health. The company's extensive portfolio includes vaccines against anthrax, rabies, and leptospirosis, as well as various diagnostic kits for agricultural and domestic animals. In addition to its veterinary focus, Kursk Biofactory produces herbal-based pharmaceuticals, dietary supplements, and traditional balsams for human consumption. The facility maintains modern manufacturing standards, including GMP-compliant lines, to support both domestic agricultural security and international exports.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kursk Biofactory.